Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The study will evaluate the efficacy and safety of ITI-007 in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.
Epistemonikos ID: 130122268c0dc087be36606e743c97daf55938b0
First added on: May 21, 2024